Search

everythinglearnresearchcommunity

for

Search:↓

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

Aggressive immunosuppressive treatment improved a woman's severe heart condition linked to autoimmune disease.

Integrating biological networks improves drug repurposing and ADR prediction.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

Researchers found a specific T cell receptor linked to severe drug reactions like Stevens-Johnson syndrome when patients take carbamazepine.

PPARγ signaling modulation can protect hair follicle stem cells from chemotherapy-induced damage.

Distinguishing drug-induced lupus from systemic lupus is challenging and requires careful monitoring.

Higher PD-1 levels mean fewer CD8+ T cells in alopecia areata hair follicles.

Increasing PDCD4 protein may help prevent or treat some skin cancers.

Dual TCR Treg cells are common in various mouse tissues and show diverse characteristics.

A new triple drug system using nanoparticles effectively targets breast tumors in 3D models.

The choice between belimumab and anifrolumab for treating lupus depends on the patient's specific symptoms.

BBR-SA nanomedicine is a safe and effective treatment for breast cancer.

Sex and race affect immune responses and treatment outcomes in Hidradenitis suppurativa.

TAK-279 effectively reduces psoriasis symptoms and is safe.

Two peptides, RMYYY and VMYMI, may be effective anti-inflammatory drugs.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

rPanglaoDB helps study rare cell types by merging RNA data, showing fibrocytes aid in healing.

CEP135 may predict cancer outcomes, and targeting PLK1 could help treat certain sarcomas.

Pembrolizumab can cause serious liver issues, requiring close monitoring and early treatment.

Abatacept may help some people with alopecia areata regrow hair.

Oral minoxidil can help regrow hair lost from antibody-drug conjugate treatment.

Most patients successfully switched from the original adalimumab to a biosimilar with few reverting due to reduced effectiveness or side effects.

The PS-b-PAA copolymer nanomicelles are effective for delivering a cancer treatment drug in photodynamic therapy.

Analog 23 is a promising compound for prostate cancer treatment.

Combining DHT and EDC improves the strength and stability of PADM scaffolds for tissue engineering.

Targeting NETs may help reduce fibrosis in Crohn's disease.

Immune checkpoint inhibitors can increase the risk of autoimmune skin diseases, especially bullous pemphigoid.

A medication for skin rash also unexpectedly treated hair loss in a patient.